[Contrast induced nephropathy]. - Wikidata - awgldk - TriplyDB

[Contrast induced nephropathy].

[Contrast induced nephropathy].

http://www.wikidata.org/entity/Q46099614

about

ACE-I/ARB therapy prior to contrast exposure: what should the clinician do?

P2860

Q38194146-9D2908DF-5D4D-4384-9B45-80C815CE7664

P2860

[Contrast induced nephropathy].

http://www.wikidata.org/entity/Q46099614

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

[Contrast induced nephropathy].

@en

[Contrast induced nephropathy].

@nl

type

label

[Contrast induced nephropathy].

@en

[Contrast induced nephropathy].

@nl

prefLabel

[Contrast induced nephropathy].

@en

[Contrast induced nephropathy].

@nl

P1433

Q46099614-ED3E1BEB-3526-4590-B4BD-FDEB9BF5C6C5

P1476

Q46099614-4E41BE01-DFE0-4559-8498-8D59BFE1D36D

P2093

Q46099614-432C0ACF-50D3-47C6-915F-2F057EE9A48B

P2860

Q46099614-00013EB7-9501-4E98-B412-582C505682D0

Q46099614-0218224E-8301-47A6-A9B8-4E8602E214FD

Q46099614-0223DAB0-F4F6-4A9B-B586-EFF41C001AD5

Q46099614-044E2596-8545-41CA-83CC-E7C02BEA6CF7

Q46099614-098F88D6-56D6-4D50-AF98-516574C668A6

Q46099614-0A29ABC4-0FD1-46D1-A64E-D2A60EE936A1

Q46099614-0B6A2424-6EA7-41FB-B979-F891FA7CE283

Q46099614-0B8E5D46-5F59-49E9-911E-35B952ADBBBE

Q46099614-1448C9F6-9C43-42EF-80FF-DC51D47C73ED

Q46099614-1675653E-7987-4F58-80BC-92450DA0C8B3

P2888

Q46099614-D1B29A49-B005-42D1-810F-D643B8F313CD

P304

Q46099614-29E90C7C-C6CD-467A-8320-65D1D52C6B6D

P31

Q46099614-C38E02CE-D99D-4D20-BABF-4941A09500BF

P356

Q46099614-6DD51C47-3AF7-4CF3-82C8-7EB6CADF255F

P407

Q46099614-87F5673B-FA9D-4D53-A3D5-0E73B8EB7063

P433

Q46099614-18D07003-23B2-4728-A17E-8AE9E1692D61

P478

Q46099614-1394651A-CC92-4122-94AA-1156059DDB18

P577

Q46099614-895FA44C-4E25-4117-9C41-F15AFD7E0164

P698

Q46099614-8FC0EC7C-BC7B-4156-B82A-1661742ADC45

P356

S00508-009-1145-3

P1433

Wiener Klinische Wochenschrift

P1476

[Contrast induced nephropathy].

@en

P2093

Walter H Hörl

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis

Clinical practice. Preventing nephropathy induced by contrast medium

Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy.

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.

Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up.

P2888

s00508-009-1145-3

P304

15-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00508-009-1145-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19263010

http://www.w3.org/2001/XMLSchema#string